Studying a New COVID-19 Vaccine among Patients who have Received a Cell Therapy

About This Study

The purpose of this study is to see if a new vaccine called GEO-CM04S1can help people who have received a cell therapy build protection from COVID-19. We want to compare this new vaccine to the current COVID-19 vaccines and see which one will work better.

Volunteers must have received a cell therapy for a blood cancer. Study team will provide more information.

What Activities Are a Part of this Study?

Informed Consent Review
Use of Study Treatments or Placebo
Review of Medical History
Physical Examinations
Study Visits and Consultations
Laboratory and Imaging Tests
Specimen Sample Collection
Diary/e-Diary Writing or Recordings

Age & Gender

18 - 100 years old
All Genders

Language

This study enrolls English speakers only

Additional Study Information

Compensation Offered
No reimbursement offered

Study Locations

Greater Winston-Salem, NC

Study Topics

Infectious Diseases

Study Locations and Contacts

Greater Winston-Salem, NC: Rica Abbott rabbott@wakehealth.edu

Study Information
IRB Number: IRB00093651

Helpful Information

Have questions? See if your question is answered in our most common question and answers section. Need to know what something means? Browse the dictionary for explanation of common clinical study terms.